Neuromyotonia: clinical profile of twenty cases from northwest India.
OBJECTIVE
We are presenting 20 cases of the intriguing clinico-electromyographic entity, now considered a potassium channel disorder, Neuromyotonia. Our experience with the clinical manifestations, underlying abnormalities and response to various therapies is documented.


METHODS
Patients with diffuse pain or undulating muscle movements, with or without stiffness were sent for electromyographic and further studies. Patients with "neuromyotonic discharges" were included after exclusion of hypocalcaemia.


RESULTS
Our cases included 19 males and one female of age group 15 to 52 years, the majority being between 30 to 45 years. Undulating movements were seen in 19, of which two had focal twitching. Muscle stiffness was a complaint in five; pain was the chief presenting complaint of 19, which started in the calf in all. Irritability, insomnia and a peculiar worried pinched face were present in 12 patients. CSF was abnormal with mildly raised protein in eight. Curiously, 11 of these patients had taken ayurvedic treatment for various complaints in the preceding one month. Bell's palsy was associated in four, peripheral neuropathy in two and residual poliomyelitis in two. Electromyographic evidence of spontaneous activity in the form of "neuromyotonic discharges" was seen in all. Antibodies to voltage gated potassium channels was tested in one patient and was positive (titer was 1028 pM). Membrane stabilizers (e.g, phenytoin sodium) in our experience did not provide adequate rapid relief; we tried high-dose intravenous Methylprednisolone in 19 with significant amelioration of complaints. One patient was offered intravenous immunoglobulin, to which he responded.


CONCLUSIONS
Neuromyotonia is a heterogeneous condition and can present in varied ways including diffuse nonspecific pain. This uncommon condition is potentially treatable and can be picked up with high index of suspicion.
Panagariya
Ashok
A
Department of Neurology, SMS Medical College, Jaipur, Rajasthan, India. ashok_panagariya@hotmail.com
Kumar
Hrishikesh
H
Mathew
Vivek
V
Sharma
Bhawna
B
D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D004576:Electromyography; D005260:Female; D006801:Humans; D007194:India; D020386:Isaacs Syndrome / Q000175:diagnosis / Q000473:pathology* / Q000503:physiopathology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D010146:Pain / Q000209:etiology; D024642:Potassium Channels, Voltage-Gated / Q000276:immunology / Q000502:physiology
D000893:Anti-Inflammatory Agents; D024642:Potassium Channels, Voltage-Gated; D008775:Methylprednisolone